Clinical features, management, and outcomes of immune checkpoint inhibitor–related cardiotoxicity
…, Y Ancedy, M Orabona, J Pinto, S Monestier… - Circulation, 2017 - Am Heart Assoc
Immune checkpoint inhibitors (ICIs) represent a major advance in the treatment of cancer.
Although clinical trials reported a low incidence of immune-related cardiovascular adverse …
Although clinical trials reported a low incidence of immune-related cardiovascular adverse …
Anti-PD1 pembrolizumab can induce exceptional fulminant type 1 diabetes
C Gaudy, C Clévy, S Monestier, N Dubois… - Diabetes …, 2015 - Am Diabetes Assoc
A 44-year-old Caucasian woman with no history of diabetes was admitted to the emergency
department in 2014 for vomiting and confusion, with polyuria, polydipsia, and a very recent …
department in 2014 for vomiting and confusion, with polyuria, polydipsia, and a very recent …
[HTML][HTML] Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery
…, L Troin, N Malissen, A Loundou, S Monestier… - European Journal of …, 2017 - Elsevier
Background Targeted therapy (TT) and immunotherapies (ITs) have dramatically improved
survival in metastatic melanoma (MM). However, their efficacy on brain metastasis (BM) …
survival in metastatic melanoma (MM). However, their efficacy on brain metastasis (BM) …
Ugly duckling sign as a major factor of efficiency in melanoma detection
…, G Pellacani, J Malvehy, MF Avril, S Monestier… - JAMA …, 2017 - jamanetwork.com
Importance Understanding the contribution of the ugly duckling sign (a nevus that is
obviously different from the others in a given individual) in intrapatient comparative analysis …
obviously different from the others in a given individual) in intrapatient comparative analysis …
A severe case of ipilimumab-induced guillain-barré syndrome revealed by an occlusive enteric neuropathy: a differential diagnosis for ipilimumab-induced colitis
C Gaudy-Marqueste, S Monestier… - Journal of …, 2013 - journals.lww.com
Ipilimumab is a fully human monoclonal antibody directed against cytotoxic T-lymphocyte
antigen-4 recently approved for the treatment of metastatic melanoma and currently under …
antigen-4 recently approved for the treatment of metastatic melanoma and currently under …
[HTML][HTML] On demand Gamma-Knife strategy can be safely combined with BRAF inhibitors for the treatment of melanoma brain metastases
…, R Carron, C Delsanti, A Loundou, S Monestier… - Annals of …, 2014 - Elsevier
ABSTRACT Background Both Gamma-Knife radiosurgery (GKRS) and BRAF inhibitors
(BRAF-I) have been shown to be useful in melanoma patients with brain metastases (BMs) …
(BRAF-I) have been shown to be useful in melanoma patients with brain metastases (BMs) …
Follow-up of patients with complete remission of locally advanced basal cell carcinoma after vismodegib discontinuation: a multicenter French study of 116 patients
…, B Guillot, G Jeudy, C Mateus, S Monestier… - Journal of clinical …, 2019 - ascopubs.org
PURPOSE Vismodegib is a hedgehog pathway inhibitor indicated for the treatment of locally
advanced basal cell carcinoma (laBCC), with an objective response rate of 65%, including a …
advanced basal cell carcinoma (laBCC), with an objective response rate of 65%, including a …
[PDF][PDF] Low-dose IL-2 for treating moderate to severe alopecia areata: a 52-week multicenter prospective placebo-controlled study assessing its impact on T regulatory …
…, H Montaudié, JP Lacour, S Monestier… - Journal of Investigative …, 2021 - Elsevier
The treatment of severe alopecia areata (AA) remains highly challenging. A breakdown of
immune privilege of the hair follicle resulting in the development of an admixed immune …
immune privilege of the hair follicle resulting in the development of an admixed immune …
Efficacy of imiquimod in the management of lentigo maligna
…, S Debarbieux, N Meyer, S Monestier… - Journal of the …, 2023 - Wiley Online Library
Background Lentigo maligna (LM) is a melanocytic proliferation occurring on photo‐
exposed skin that may progress to LM melanoma. Surgery is recommended as first‐line …
exposed skin that may progress to LM melanoma. Surgery is recommended as first‐line …
Diabetes and blood glucose disorders under anti-PD1
…, N Malissen, L Troin, S Monestier… - Journal of …, 2018 - journals.lww.com
Abstract Acute type 1 diabetes (AD1) is a rare but definitive immune-related adverse event
associated with anti-PD1. Most of the reported cases are close to what has been described …
associated with anti-PD1. Most of the reported cases are close to what has been described …